Verenigde Staten - Engels - NLM (National Library of Medicine)

mckesson corporation dba sky packaging - nimodipine (unii: 57wa9qz5wh) (nimodipine - unii:57wa9qz5wh) - nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., hunt and hess grades i-v). the concomitant use of nimodipine with strong inhibitors of cyp3a4 such as some macrolide antibiotics (e.g., clarithromycin, telithromycin), some anti-hiv protease inhibitors (e.g., delaviridine, indinavir, nelfinavir, ritonavir, saquinavir), some azole antimycotics (e.g., ketoconazole, itraconazole, voriconazole) and some antidepressants (e.g., nefazadone) is contraindicated because of a risk of significant hypotension (see precautions, drug interactions ). there have been no reported instances of drug abuse or dependence with nimodipine capsules.

Verenigde Staten - Engels - NLM (National Library of Medicine)

heritage pharmaceuticals inc. - nimodipine (unii: 57wa9qz5wh) (nimodipine - unii:57wa9qz5wh) - nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., hunt and hess grades i-v). the concomitant use of nimodipine with strong inhibitors of cyp3a4 such as some macrolide antibiotics (e.g., clarithromycin, telithromycin), some anti-hiv protease inhibitors (e.g., delaviridine, indinavir, nelfinavir, ritonavir, saquinavir), some azole antimycotics (e.g., ketoconazole, itraconazole, voriconazole) and some antidepressants (e.g., nefazadone) is contraindicated because of a risk of significant hypotension (see precautions, drug interactions) there have been no reported instances of drug abuse or dependence with nimodipine

Verenigde Staten - Engels - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd. - nimodipine (unii: 57wa9qz5wh) (nimodipine - unii:57wa9qz5wh) - nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., hunt and hess grades i-v). the concomitant use of nimodipine with strong inhibitors of cyp3a4 such as some macrolide antibiotics (e.g., clarithromycin, telithromycin), some anti-hiv protease inhibitors (e.g., delaviridine, indinavir, nelfinavir, ritonavir, saquinavir), some azole antimycotics (e.g., ketoconazole, itraconazole, voriconazole) and some antidepressants (e.g., nefazadone) is contraindicated because of a risk of significant hypotension (see precautions, drug interactions ). there have been no reported instances of drug abuse or dependence with nimodipine.

Verenigde Staten - Engels - NLM (National Library of Medicine)

arbor pharmaceuticals - nimodipine (unii: 57wa9qz5wh) (nimodipine - unii:57wa9qz5wh) - nimodipine 60 mg in 20 ml - nymalize is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (sah) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., hunt and hess grades i-v). none. risk summary there are no adequate data on the developmental risk associated with the use of nymalize in pregnant women. in animal studies, oral administration of nimodipine during pregnancy resulted in adverse effects on development (increased embryofetal mortality, increased incidences of fetal structural abnormalities, decreased fetal growth) at doses equivalent to (rat) or less than (rabbit) those used clinically [see data] . in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 2-4% and 15-20% respectively. the background risk of major birth defects and miscarriage for the indicated population is unknow

Malta - Engels - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - nimodipine - solution for infusion - nimodipine 10/50 mg/ml - calcium channel blockers

Malta - Engels - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - nimodipine - coated tablet - nimodipine 30 mg - calcium channel blockers

Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

imeks pharma sdn. bhd. - nimodipine -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - nifedipine, quantity: 30 mg - tablet, modified release - excipient ingredients: carbomer 934p; titanium dioxide; povidone; purified talc; iron oxide red; macrogol 4000; hypromellose; magnesium stearate; colloidal anhydrous silica; lactose monohydrate; basic butylated methacrylate copolymer - treatment of hypertension. prophylaxis of chronic stable angina pectoris.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - nifedipine, quantity: 30 mg - tablet, modified release - excipient ingredients: hypromellose; povidone; colloidal anhydrous silica; titanium dioxide; iron oxide red; macrogol 4000; lactose monohydrate; magnesium stearate; purified talc; carbomer 934p; basic butylated methacrylate copolymer - treatment of hypertension. prophylaxis of chronic stable angina pectoris.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - nifedipine, quantity: 30 mg - tablet, modified release - excipient ingredients: magnesium stearate; cellulose acetate; polyethylene oxide; macrogol 3350; hypromellose; iron oxide red; sodium chloride; titanium dioxide; propylene glycol; hyprolose; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - indications: nifedipine is indicated for: 1. the treatment of mild to moderate hypertension. 2. the prophylaxis of chronic stable angina pectoris.